3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
17
Lung Neoplasms
7
Small Cell Lung Carcinoma
5
Neoplasms
4
Carcinoma, Hepatocellular
4
Carcinoma
4
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Cholangiocarcinoma
3
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Liver Neoplasms
2
Gallbladder Neoplasms
2
Endometrial Neoplasms
2
Bile Duct Neoplasms
2
Vaccinia
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Non-Small Cell Lung Cancer Metastatic
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Mouth Neoplasms
1
Liver Diseases
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Interventions
Cisplatin
6
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Fulvestrant
3
pembrolizumab
2
palbociclib
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Radiation Dose Hypofractionation
2
Radiation
2
Platinum
2
Paclitaxel
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Congresses as Topic
2
Carboplatin
2
Brachytherapy
2
Biopsy
2
Bevacizumab
2
Axitinib
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
1,2-diaminocyclohexaneplatinum II citrate
2
zimberelimab
1
ulixertinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tisotumab vedotin
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
durvalumab
×
30 days
×
Clear all
No trials found.